NO321650B1 - Fremgangsmate for okning av veksthastigheten til salmonid fisk, transgen salmonid fisk, analyse, promotersekvens, chimerisk genkonstruksjon og fiskevert. - Google Patents
Fremgangsmate for okning av veksthastigheten til salmonid fisk, transgen salmonid fisk, analyse, promotersekvens, chimerisk genkonstruksjon og fiskevert. Download PDFInfo
- Publication number
- NO321650B1 NO321650B1 NO19933276A NO933276A NO321650B1 NO 321650 B1 NO321650 B1 NO 321650B1 NO 19933276 A NO19933276 A NO 19933276A NO 933276 A NO933276 A NO 933276A NO 321650 B1 NO321650 B1 NO 321650B1
- Authority
- NO
- Norway
- Prior art keywords
- fish
- sequence
- promoter
- transgenic
- gene
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 148
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 136
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 120
- 238000000034 method Methods 0.000 title claims description 20
- 230000012010 growth Effects 0.000 title claims description 18
- 241001507086 salmonid fish Species 0.000 title claims description 16
- 238000003556 assay Methods 0.000 title claims description 6
- 235000019688 fish Nutrition 0.000 claims description 125
- 241000972773 Aulopiformes Species 0.000 claims description 67
- 235000019515 salmon Nutrition 0.000 claims description 67
- 108010051696 Growth Hormone Proteins 0.000 claims description 59
- 102000018997 Growth Hormone Human genes 0.000 claims description 59
- 239000000122 growth hormone Substances 0.000 claims description 59
- 239000012634 fragment Substances 0.000 claims description 33
- 238000004458 analytical method Methods 0.000 claims description 32
- 210000004027 cell Anatomy 0.000 claims description 31
- 108091027963 non-coding RNA Proteins 0.000 claims description 23
- 102000042567 non-coding RNA Human genes 0.000 claims description 23
- 241000277263 Salmo Species 0.000 claims description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
- 241000277331 Salmonidae Species 0.000 claims description 15
- 238000010276 construction Methods 0.000 claims description 12
- 241001280377 Oncorhynchus tshawytscha Species 0.000 claims description 8
- 230000000692 anti-sense effect Effects 0.000 claims description 8
- 241000269913 Pseudopleuronectes americanus Species 0.000 claims description 7
- 210000004185 liver Anatomy 0.000 claims description 7
- 230000002103 transcriptional effect Effects 0.000 claims description 7
- 241001086438 Euclichthys polynemus Species 0.000 claims description 6
- 108091081021 Sense strand Proteins 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 241001233037 catfish Species 0.000 claims description 5
- 230000035897 transcription Effects 0.000 claims description 5
- 238000013518 transcription Methods 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 241001502129 Mullus Species 0.000 claims description 2
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 210000004602 germ cell Anatomy 0.000 claims description 2
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- 238000012546 transfer Methods 0.000 abstract description 17
- 230000002528 anti-freeze Effects 0.000 abstract description 10
- 210000002257 embryonic structure Anatomy 0.000 abstract description 9
- 239000013615 primer Substances 0.000 description 62
- 108020004414 DNA Proteins 0.000 description 45
- 239000013612 plasmid Substances 0.000 description 24
- 241000276569 Oryzias latipes Species 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 19
- 241000269785 Zoarces americanus Species 0.000 description 19
- 101150055123 afp gene Proteins 0.000 description 18
- 108700019146 Transgenes Proteins 0.000 description 16
- 210000003754 fetus Anatomy 0.000 description 16
- 230000014509 gene expression Effects 0.000 description 15
- 239000002299 complementary DNA Substances 0.000 description 14
- 235000013601 eggs Nutrition 0.000 description 14
- 230000037396 body weight Effects 0.000 description 11
- 239000013598 vector Substances 0.000 description 11
- 230000004927 fusion Effects 0.000 description 10
- 230000005030 transcription termination Effects 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 241000277275 Oncorhynchus mykiss Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 108010053481 Antifreeze Proteins Proteins 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000010222 PCR analysis Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000008488 polyadenylation Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000001052 transient effect Effects 0.000 description 5
- 238000002105 Southern blotting Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000002308 embryonic cell Anatomy 0.000 description 4
- 230000012447 hatching Effects 0.000 description 4
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 241000277334 Oncorhynchus Species 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108700026226 TATA Box Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 241000269370 Xenopus <genus> Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000000520 microinjection Methods 0.000 description 3
- 238000009372 pisciculture Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000269858 Anarhichas lupus Species 0.000 description 2
- 241000323766 Barbatula Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000218590 Cobitis Species 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 108010000521 Human Growth Hormone Proteins 0.000 description 2
- 102000003792 Metallothionein Human genes 0.000 description 2
- 108090000157 Metallothionein Proteins 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- 241000277289 Salmo salar Species 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 241000276424 Xiphophorus Species 0.000 description 2
- 241000276425 Xiphophorus maculatus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000975 co-precipitation Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
- 241000252229 Carassius auratus Species 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 241000555804 Girardinus Species 0.000 description 1
- 241000276572 Hemitripterus americanus Species 0.000 description 1
- 102000009824 Hepatocyte Nuclear Factor 1-alpha Human genes 0.000 description 1
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241001165050 Ocala Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102000006877 Pituitary Hormones Human genes 0.000 description 1
- 108010047386 Pituitary Hormones Proteins 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101000868151 Rattus norvegicus Somatotropin Proteins 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010049692 Type I Antifreeze Proteins Proteins 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- -1 deoxyribonucleotide triphosphates Chemical class 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009554 growth spurt Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- RYZCLUQMCYZBJQ-UHFFFAOYSA-H lead(2+);dicarbonate;dihydroxide Chemical compound [OH-].[OH-].[Pb+2].[Pb+2].[Pb+2].[O-]C([O-])=O.[O-]C([O-])=O RYZCLUQMCYZBJQ-UHFFFAOYSA-H 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66976591A | 1991-03-15 | 1991-03-15 | |
PCT/CA1992/000109 WO1992016618A1 (en) | 1991-03-15 | 1992-03-12 | Gene construct for production of transgenic fish |
Publications (3)
Publication Number | Publication Date |
---|---|
NO933276D0 NO933276D0 (no) | 1993-09-14 |
NO933276L NO933276L (no) | 1993-11-11 |
NO321650B1 true NO321650B1 (no) | 2006-06-19 |
Family
ID=24687639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19933276A NO321650B1 (no) | 1991-03-15 | 1993-09-14 | Fremgangsmate for okning av veksthastigheten til salmonid fisk, transgen salmonid fisk, analyse, promotersekvens, chimerisk genkonstruksjon og fiskevert. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5545808A (de) |
EP (1) | EP0578653B1 (de) |
JP (1) | JP3293622B2 (de) |
AT (1) | ATE203269T1 (de) |
AU (1) | AU669844B2 (de) |
CA (2) | CA2367129A1 (de) |
DE (1) | DE69231947T2 (de) |
ES (1) | ES2163398T3 (de) |
NO (1) | NO321650B1 (de) |
WO (1) | WO1992016618A1 (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6395959B1 (en) | 1992-05-05 | 2002-05-28 | Institut Pasteur | Nucleotide sequence encoding the enzyme I SceI and the use thereof |
GB9216851D0 (en) * | 1992-08-07 | 1992-09-23 | Univ Manitoba | Dna sequences of rat probasin gene |
CN1070917C (zh) * | 1993-06-10 | 2001-09-12 | 诺沃挪第克公司 | 编码胰岛素受体底物1的突变dna |
US5888981A (en) | 1993-06-14 | 1999-03-30 | Basf Aktiengesellschaft | Methods for regulating gene expression |
WO1994029442A2 (en) | 1993-06-14 | 1994-12-22 | Basf Aktiengesellschaft | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
US5866755A (en) * | 1993-06-14 | 1999-02-02 | Basf Aktiengellschaft | Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
US5859310A (en) | 1993-06-14 | 1999-01-12 | Basf Aktiengesellschaft | Mice transgenic for a tetracycline-controlled transcriptional activator |
US5912411A (en) * | 1993-06-14 | 1999-06-15 | University Of Heidelberg | Mice transgenic for a tetracycline-inducible transcriptional activator |
GB9316727D0 (en) * | 1993-08-12 | 1993-09-29 | Inst Of Psychiatry | Models of alzheimers's disease |
US5789655A (en) | 1994-05-13 | 1998-08-04 | The Regents Of The University Of California | Transgenic animals expressing artificial epitope-tagged proteins |
CA2126138C (en) * | 1994-06-17 | 2001-08-21 | Robert H. Devlin | Transgenic fish and vectors therefor |
US5907078A (en) * | 1994-12-09 | 1999-05-25 | Greenberg; Norman M. | Transgenic mouse model for prostate cancer |
BR9606298A (pt) * | 1995-04-06 | 1997-12-23 | Univ Dalhousie | Peixe transgênico no tratamento de diabetes |
US5986054A (en) * | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
US6531586B1 (en) | 1995-04-28 | 2003-03-11 | The Hospital For Sick Children | Genetic sequences related to Alzheimer's Disease |
US6210919B1 (en) * | 1995-04-28 | 2001-04-03 | Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
JP2000513923A (ja) * | 1995-07-18 | 2000-10-24 | ワシントン・ユニバーシティ | 変異s182遺伝子 |
WO1997009350A1 (en) * | 1995-09-07 | 1997-03-13 | Ppl Therapeutics (Scotland) Ltd. | Purification of alpha-1 proteinase inhibitor |
US5780448A (en) * | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
JPH11511338A (ja) * | 1996-01-31 | 1999-10-05 | エイチエスシー リサーチ アンド ディヴェロップメント リミテッド パートナーシップ | 細胞内不凍ポリペプチド又は核酸 |
US6333447B1 (en) * | 1996-03-29 | 2001-12-25 | The General Hospital Corporation | Transgenic model of heart failure |
US5955644A (en) * | 1996-08-08 | 1999-09-21 | M.D. Anderson Cancer Center | Ku deficient cells and non-human transgenic animals |
DE69735498T2 (de) | 1996-09-26 | 2006-11-09 | The Regents Of The University Of Colorado, Boulder | Transgenes modell für herzversagen |
GB9621113D0 (en) * | 1996-10-10 | 1996-11-27 | Univ Southampton | Transgenic fish |
US5859314A (en) * | 1996-10-18 | 1999-01-12 | Ludwig Institute For Cancer Research | Mice with targeted tyrosine kinase, lyn, disruption |
US6066778A (en) * | 1996-11-06 | 2000-05-23 | The Regents Of The University Of Michigan | Transgenic mice expressing APC resistant factor V |
US6448470B1 (en) * | 1997-02-25 | 2002-09-10 | Thomas Jefferson University | Transgenic COL2A1-null mice expressing human COL2A1 |
US6380458B1 (en) * | 1997-06-09 | 2002-04-30 | Medical College Of Georgia Research Institute, Inc. | Cell-lineage specific expression in transgenic zebrafish |
US7087420B1 (en) | 1997-07-17 | 2006-08-08 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
US6391547B1 (en) * | 1997-09-09 | 2002-05-21 | Center For The Application Of Molecular Biology To International Agriculture | Microbial β-glucuronidase genes, gene products and uses thereof |
DE69926629T2 (de) * | 1998-05-31 | 2006-06-08 | University Of Georgia Research Foundation, Inc. | Transgene fische, die ein von bakteriophagen abgeleitetes transgenes konstrukt zum nachweis von mutationen tragen |
US6429293B1 (en) | 1998-06-26 | 2002-08-06 | Hsc Research And Development Limited Partnership | Sculpin-type antifreeze polypeptides and nucleic acids |
US6245966B1 (en) * | 1998-07-14 | 2001-06-12 | University Technology Corporation | Adenoviral mediated gene transfer into lymphocytes |
WO2000024246A2 (en) | 1998-10-26 | 2000-05-04 | The University Of Georgia Research Foundation, Inc. | Transgenic fish carrying plasmid for mutation detection and methods |
US6864235B1 (en) | 1999-04-01 | 2005-03-08 | Eva A. Turley | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
US6911429B2 (en) * | 1999-04-01 | 2005-06-28 | Transition Therapeutics Inc. | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
WO2001094378A1 (en) * | 2000-06-08 | 2001-12-13 | The Research Foundation Of State University Of New York | Nucleic acid sequences encoding type iii tenebrio antifreeze proteins and method for assaying activity |
US6951739B2 (en) * | 2000-10-12 | 2005-10-04 | Marical, Inc. | Polyvalent cation-sensing receptor in atlantic salmon |
US6979558B2 (en) * | 2000-10-12 | 2005-12-27 | Marical, Inc. | Polyvalent cation-sensing receptor in Atlantic salmon |
US6979559B2 (en) * | 2000-10-12 | 2005-12-27 | Marical, Inc. | Polyvalent cation-sensing receptor in atlantic salmon |
US7101988B2 (en) * | 2000-10-12 | 2006-09-05 | Marical, Inc. | Polyvalent cation-sensing receptor in Atlantic salmon |
WO2003087331A2 (en) * | 2000-10-12 | 2003-10-23 | Marical, Inc. | Polyvalent cation-sensing receptor in atlantic salmon |
AU2003232002A1 (en) * | 2002-04-11 | 2003-10-27 | Marical, Inc. | Polyvalent cation-sensing receptor in atlantic salmon |
US7183079B2 (en) * | 2002-11-06 | 2007-02-27 | Auburn University | Compositions and methods for enhancing disease resistance in fish |
US20100077654A1 (en) * | 2008-09-23 | 2010-04-01 | LiveFuels, Inc. | Systems and methods for producing biofuels from algae |
US20110239318A1 (en) * | 2008-11-18 | 2011-09-29 | LiveFuels, Inc. | Methods for producing fish with high lipid content |
JP5681494B2 (ja) | 2009-02-13 | 2015-03-11 | 株式会社カネカ | 氷結晶化阻害物質を含む植物抽出物およびその製造方法 |
WO2010121094A1 (en) | 2009-04-17 | 2010-10-21 | Livefuels. Inc. | Systems and methods for culturing algae with bivalves |
JP2010285359A (ja) | 2009-06-09 | 2010-12-24 | Kaneka Corp | 植物由来氷結晶化阻害剤 |
US9149025B2 (en) * | 2010-02-19 | 2015-10-06 | Universite De Liege | Polynucleotide for use in treatment of influenza A virus induced diseases, encoding modified Mx protein, said modified Mx protein, and a transgenic animal expressing gene encoding modified Mx protein |
US9487716B2 (en) | 2011-05-06 | 2016-11-08 | LiveFuels, Inc. | Sourcing phosphorus and other nutrients from the ocean via ocean thermal energy conversion systems |
WO2014030165A1 (en) * | 2012-08-23 | 2014-02-27 | Transalgae Israel Ltd. | Transgenic microalgae and use thereof for oral delivery of proteins |
CA2935635C (en) | 2014-02-12 | 2023-05-09 | Transalgae Israel Ltd. | Algal based edible vaccines |
CN106282377B (zh) * | 2016-09-27 | 2019-09-24 | 黄埔出入境检验检疫局综合技术服务中心 | 一种转基因鲑鱼AquAdvantage品系特异性实时荧光PCR检测引物、检测方法和试剂盒 |
CN107385070A (zh) * | 2017-08-22 | 2017-11-24 | 山东出入境检验检疫局检验检疫技术中心 | 快速鉴定转基因三文鱼及其制品的方法 |
CN109371141A (zh) * | 2018-11-29 | 2019-02-22 | 岛津企业管理(中国)有限公司 | 鉴别大西洋鲑和虹鳟的方法及特异性引物对 |
-
1992
- 1992-03-12 JP JP50579192A patent/JP3293622B2/ja not_active Expired - Lifetime
- 1992-03-12 CA CA002367129A patent/CA2367129A1/en not_active Abandoned
- 1992-03-12 WO PCT/CA1992/000109 patent/WO1992016618A1/en active IP Right Grant
- 1992-03-12 AT AT92906427T patent/ATE203269T1/de not_active IP Right Cessation
- 1992-03-12 AU AU13703/92A patent/AU669844B2/en not_active Expired
- 1992-03-12 EP EP92906427A patent/EP0578653B1/de not_active Expired - Lifetime
- 1992-03-12 DE DE69231947T patent/DE69231947T2/de not_active Expired - Fee Related
- 1992-03-12 CA CA002106315A patent/CA2106315C/en not_active Expired - Lifetime
- 1992-03-12 ES ES92906427T patent/ES2163398T3/es not_active Expired - Lifetime
-
1993
- 1993-09-14 NO NO19933276A patent/NO321650B1/no not_active IP Right Cessation
-
1994
- 1994-03-10 US US08/212,375 patent/US5545808A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69231947T2 (de) | 2002-05-29 |
EP0578653A1 (de) | 1994-01-19 |
JP3293622B2 (ja) | 2002-06-17 |
JPH06505870A (ja) | 1994-07-07 |
CA2106315A1 (en) | 1992-09-16 |
NO933276L (no) | 1993-11-11 |
ATE203269T1 (de) | 2001-08-15 |
US5545808A (en) | 1996-08-13 |
CA2106315C (en) | 2005-09-13 |
NO933276D0 (no) | 1993-09-14 |
AU1370392A (en) | 1992-10-21 |
CA2367129A1 (en) | 1992-10-01 |
EP0578653B1 (de) | 2001-07-18 |
AU669844B2 (en) | 1996-06-27 |
DE69231947D1 (de) | 2001-08-23 |
ES2163398T3 (es) | 2002-02-01 |
WO1992016618A1 (en) | 1992-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO321650B1 (no) | Fremgangsmate for okning av veksthastigheten til salmonid fisk, transgen salmonid fisk, analyse, promotersekvens, chimerisk genkonstruksjon og fiskevert. | |
Sarmasik et al. | Production of transgenic medaka with increased resistance to bacterial pathogens | |
Devlin et al. | Growth, viability and genetic characteristics of GH transgenic coho salmon strains | |
CA2781619C (en) | Maternally induced sterility in animals | |
US9043995B2 (en) | Transgenic fish and uses thereof | |
Chiou et al. | Production of homozygous transgenic rainbow trout with enhanced disease resistance | |
JP2002504821A (ja) | 組織特異的発現を有するトランスジェニック魚 | |
Venugopal et al. | Growth enhancement and food conversion efficiency of transgenic fish Labeo rohita | |
Noh et al. | Genomic cloning of mud loach Misgurnus mizolepis (Cypriniformes, Cobitidae) β-actin gene and usefulness of its promoter region for fish transgenesis | |
KR102680060B1 (ko) | 바이러스에 의한 감염으로부터 돼지 태아를 보호하는 방법 | |
WO2002030183A1 (en) | Genetic control of sex ratio in animal populations | |
KR101588474B1 (ko) | 영장류 동물의 초기 배아에의 외래 유전자 도입법 및 상기 도입법을 포함하는 트랜스제닉 영장류 동물을 작출하는 방법 | |
AU2001291520B2 (en) | Genetic control of sex ratio in animal populations | |
Pandianı et al. | Contribution to transgenesis in Indian major carp Labeo rohita | |
EP2946663A1 (de) | Genetisch manipuliertes murines Tier als Modell für primäre Membrannephropathie | |
AU2001291520A1 (en) | Genetic control of sex ratio in animal populations | |
INDE | Biotechnology in Aquaculture, with Special Reference to Transgenic Salmon | |
Walker | Evaluation of salmon sperm electroporation for gene transfer | |
Lee et al. | Expression of GFP Gene Driven by the Olive Flounder (Paralichthys olivaceus) hsc70 Promoter in Trangenic Medaka (Oryzias latipes) | |
Brooks | Somatic transgenesis in Nile tilapia (Oreochromis niloticus) | |
Pandian | Transgenesis in fishes: Indian research and development. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |